Korean Registry of Non-Small Cell Lung Cancer Patients With EGFR Mutation - Trial NCT06247280

Name: Clinical Trial NCT06247280
Creator: Yuhan Corporation
Keywords: NSCLC, clinical trial, South Korea

Access comprehensive clinical trial information for NCT06247280 through Pure Global AI's free database. This phase not specified trial is sponsored by Yuhan Corporation and is currently Recruiting. The study focuses on NSCLC. Target enrollment is 2000 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database

840K+ Trials

NCT06247280

Recruiting

Trial Details

ClinicalTrials.gov • NCT06247280

View on ClinicalTrials.gov

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Korean Registry of Non-Small Cell Lung Cancer Patients With EGFR Mutation

Multicenter Prospective and Retrospective Cohort Study in Non-small Cell Lung Cancer Patients With EGFR Mutation: Korean EGFR Registry

Study Focus

Disease/Condition

NSCLC

Study Type

Observational

Sponsor & Location

Primary Sponsor

Yuhan Corporation

Location

Chilgok,Wonju,Chuncheon,Bucheon-si,Uijeongbu,Bucheon,Iksan,Busan,Busan,Busan,Busan,Busan,Changwon,Daegu,Daegu,Daegu,Daejeon,Daejeon,Hwasun,Incheon,Incheon,Pusan,Seoul,Seoul,Seoul,Seoul,Seoul,Seoul,Seo, South Korea

Timeline & Enrollment

Phase

N/A

Start Date

Jun 24, 2022

End Date

Dec 31, 2026

Enrollment

2000 participants

Primary Outcome

Clinical characteristics of NSCLC patients with EGFR mutation,Clinical outcome of NSCLS patients with EGFR mutation,PFS,DFS

Summary

Korean Registry of Non-Small Cell Lung Cancer Patients with EGFR mutation to collect and analyze the patient's clinical features, diagnosis, and treatment results.

Data Source

Registry

ClinicalTrials.gov

Trial ID

NCT06247280

Type

Non-Device Trial